Scarica l'app Stockscreener
29.24
2.78%
0.79
Pulse Biosciences Inc Borsa (PLSE) Ultime notizie
Price to sales forward of Pulse Biosciences, Inc – NASDAQ:PLSE - TradingView
Price to book forward of Pulse Biosciences, Inc – NASDAQ:PLSE - TradingView
Enterprise value to EBIT forward of Pulse Biosciences, Inc – NASDAQ:PLSE - TradingView
Price to book forward of Pulse Biosciences, Inc. – FWB:6L8 - TradingView
Enterprise value to revenue forward of Pulse Biosciences, Inc – NASDAQ:PLSE - TradingView
Enterprise value to revenue forward of Pulse Biosciences, Inc. – FWB:6L8 - TradingView
Price to sales forward of Pulse Biosciences, Inc. – FWB:6L8 - TradingView
Price to earnings forward of Pulse Biosciences, Inc. – FWB:6L8 - TradingView
Pulse Biosciences Inc (PLSE) Institutional Confidence - TradingKey
Pulse Biosciences stock hits 52-week high at $28.68 - Investing.com
Pulse Biosciences stock hits 52-week high at $28.68 By Investing.com - Investing.com UK
Pulse Biosciences, Inc. Actuals & Estimates (NASDAQ:PLSE) - TradingView
Pulse Biosciences, Inc. Actuals & Estimates (DUS:6L8) - TradingView
6L8 Forecast — Price Target — Prediction for 2027 - TradingView
Pulse Biosciences Inc (PLSE) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Companies Like Pulse Biosciences (NASDAQ:PLSE) Are In A Position To Invest In Growth - Moomoo
Pulse Biosciences Inc (PLSE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Pulse Biosciences Inc (PLSE) Valuation: PE, PB & Fair Value Analysis - TradingKey
Pulse Biosciences (PLSE) Is Up 5.0% After Joining S&P Healthcare Equipment Index Is Sentiment Shifting? - simplywall.st
Pulse Biosciences, Inc.(NasdaqCM:PLSE) added to S&P Healthcare Equipment Select Industry Index - marketscreener.com
Understanding Momentum Shifts in (PLSE) - Stock Traders Daily
Pulse Biosciences Stockweekly review and sector comparison - AD HOC NEWS
Pulse Biosciences Inc (PLSE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Pulse Biosciences Inc (PLSE) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Pulse Biosciences Strengthens Executive Team - Medical Product Outsourcing
Pulse Biosciences Inc (PLSE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Pulse Biosciences Inc (PLSE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Pulse Biosciences Inc (PLSE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
What Could New Equity Awards Signal for Pulse Biosciences’ Ongoing Growth Efforts? - Kalkine Media
Pulse Biosciences (PLSE) director awarded stock options for 44,504 shares - Stock Titan
What Do Pulse Biosciences’ New Equity Awards Reveal About Executive Compensation Trends? - Kalkine Media
Director at Pulse Biosciences (NASDAQ: PLSE) receives new stock option grants - Stock Titan
[Form 4] PULSE BIOSCIENCES, INC. Insider Trading Activity - Stock Titan
Pulse Biosciences Plunges Over 9% as Selling Pressure Intensifies, Key Support in PlayHigh Low Breadth - newsline.com
Pulse Bio to redeem remaining common stock warrants - MSN
Pulse Biosciences Shareholders Approve Board and Auditor Slate - TipRanks
Pulse Biosciences (PLSE) investors back all directors and Deloitte as 2026 auditor - Stock Titan
Pulse Biosciences (PLSE) Hovers Near Resistance After Modest GainVolume Breadth - newsline.com
Pulse Biosciences Stock (US73242P1030): Shares in focus after recent conference appearance - AD HOC NEWS
Pulse Biosciences (PLSE) upgraded to buy: What does it mean for the stock? - MSN
Pulse Biosciences Inc Annual Shareholders Meeting Transcript - GuruFocus
Pulse Biosciences (PLSE) Surges 7.6% on Increased Volume, Testing Key ResistanceSynthetic Short - newsline.com
PLSE: Directors and auditor ratified as company advances AFib trial and strengthens leadership - TradingView
Pulse Biosciences Inc at Goldman Sachs Healthcare Conference Transcript - GuruFocus
Pulse Biosciences (PLSE) to Redeem Outstanding Warrants by June 2026 - GuruFocus
PLSE: Nanosecond PFA platform shows high efficacy in AFib, with FDA approval targeted for late 2027 - TradingView
Pulse Biosciences, Inc. Announces Planned Redemption of Warrants - Investing News Network
Pulse Bio to redeem common stock warrants (PLSE:NASDAQ) - Seeking Alpha
Pulse Biosciences Announces Redemption of Remaining 200% Warrants - TipRanks
Pulse Biosciences to redeem remaining warrants after VWAP triggers; exercise window until July 13, 2026 - TradingView
Warrant redemption may add up to $2.1M for Pulse Biosciences (PLSE) - Stock Titan
Pulse Biosciences to redeem outstanding warrants by July 13 - Investing.com UK
Pulse Biosciences, Inc. Announces Planned Redemption Of Warrants - TradingView
Avoiding Lag: Real-Time Signals in (PLSE) Movement - Stock Traders Daily
Did New Analyst Coverage and Insider Buying Just Shift Pulse Biosciences' (PLSE) Investment Narrative? - Yahoo Finance
0.09%
0.52%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):